AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
ALZCUR | ST
Overview
Corporate Details
- ISIN(s):
- SE0010133785 (+1 more)
- LEI:
- 5493001EJLEBXFY6I446
- Country:
- Sweden
- Address:
- Hälsovägen 7, 141 57 Huddinge
Description
AlzeCure Pharma is a pharmaceutical company engaged in the research and development of therapies for severe diseases, with a primary focus on Alzheimer's disease and a secondary focus on pain. The company develops a broad portfolio of symptomatic, disease-modifying, and preventive drug candidates. Its research is centered on two key platforms: NeuroRestore, which focuses on symptomatic treatments, and Alzstatin, which develops disease-modifying and preventive candidates for early-stage Alzheimer's. A lead candidate from the NeuroRestore platform, ACD856, is advancing to Phase II clinical trials for Alzheimer's disease. The company's strategy is to address high unmet medical needs in central nervous system (CNS) disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AlzeCure Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AlzeCure Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AlzeCure Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
